Skip to contentM
Microbot Medical Inc.
M
MBOTMicrobot Medical Inc. Q1 2019 · 10-Q
Revenue—
Net Income-$1.96M-$1.96MN/M vs Q1 2018 EPS Diluted-$0.48-$0.48N/M vs Q1 2018 Operating Income-$1,916,000N/M Operating Cash Flow-$2,723,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Microbot Medical Inc. · CIK 883975 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 15, 2019 · 45 d after period end